Clinical trial
Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy (MCPAIN)
NCT07795593 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy (MCPAIN)
- Lead sponsor
- University of Michigan
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- October 31, 2031
- Enrollment
- 600 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathies, painful diabetic neuropathy (pdn)